Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentAsset Writedowns and ImpairmentDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionFree Cash FlowFree Cash FlowNet Cash FlowNet Cash FlowNet IncomeShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Intelligent Bio Solutions (INBS) Cash from Financing Activities (2020 - 2025)

Intelligent Bio Solutions has reported Cash from Financing Activities over the past 4 years, most recently at $10.8 million for Q1 2024.

  • For Q1 2024, Cash from Financing Activities rose 526.97% year-over-year to $10.8 million; the TTM value through Mar 2024 reached $12.5 million, down 42.58%, while the annual FY2023 figure was $1.4 million, N/A changed from the prior year.
  • Cash from Financing Activities for Q1 2024 was $10.8 million at Intelligent Bio Solutions, up from $46110.0 in the prior quarter.
  • Over five years, Cash from Financing Activities peaked at $19.6 million in Q4 2020 and troughed at $46110.0 in Q2 2023.
  • A 4-year average of $5.2 million and a median of $1.7 million in 2023 define the central range for Cash from Financing Activities.
  • On a YoY basis, Cash from Financing Activities climbed as much as 526.97% in 2024 and fell as far as 526.97% in 2024.
  • Year by year, Cash from Financing Activities stood at $19.6 million in 2020, then plummeted by 97.46% to $498100.0 in 2021, then plummeted by 90.74% to $46110.0 in 2023, then skyrocketed by 23255.19% to $10.8 million in 2024.
  • Business Quant data shows Cash from Financing Activities for INBS at $10.8 million in Q1 2024, $46110.0 in Q2 2023, and $1.7 million in Q1 2023.